CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Adcock Ingram Holdings Limited is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Adcock Ingram Holdings Limited
1 New Road New Road & 7th Street Midrand
Phone: +27 116350000p:+27 116350000 JOHANNESBURG, 1682  South Africa Ticker: AIPAIP

Business Summary
Adcock Ingram Holdings Limited is a healthcare company. The Company is a pharmaceutical manufacturer, which manufactures, markets and distributes a range of healthcare products, and supplies to both the private and public sectors of the market. The Company's segments include Over the Counter (OTC), Consumer, Prescription and Hospital. The OTC segment focuses primarily on brands sold predominantly in the pharmacy market. The Consumer segment is engaged in the fast moving consumer goods (FMCG) space. The Prescription segment markets products prescribed by medical practitioners. The Hospital segment operates as a supplier of hospital and critical care products, including intravenous solutions, blood collection products and renal dialysis systems. The Company's products include Allergex Non-Drowsy, Panado Paed Syrups, Probiflora Infant, Cepacol, Medi-Keel A, Adco-Acyclovir Topical Cream and Adco-Normospor Vaginal Cream.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
Morningstar
Rating
YesYes-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20196/30/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Lindsay P.Ralphs 64 7/1/2019 4/10/2014
Chief Executive Officer, Executive Director Andrew G.Hall 57 11/11/2015 7/15/2008
Chief Financial Officer, Executive Director DoretteNeethling 45 2/23/2016 8/1/2007
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Adcock Ingram Critical Care Pty Ltd. P.O. Box 6888 Johannesburg South Africa

Business Names
Business Name
Adcock Ingram Critical Care (Pty) Limited
Adcock Ingram East Africa Limited
Adcock Ingram Healthcare (Pty) Limited
15 additional Business Names available in full report.

General Information
Number of Employees: 2,610 (As of 6/30/2018)
Outstanding Shares: 171,432,861 (As of 7/30/2019)
Shareholders: 5,741
Stock Exchange: JNB
Fax Number: +27 865530000


Copyright © 2019 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 10, 2019